Analysts expect Arcutis Biotherapeutics, Inc. to report revenue of 150.91 M for Q3 26, against a range of 146.19 M to 155.64 M. The most recent reported quarter, Q2 26, came in at 129.86 M, a 12.4% beat against the 115.49 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 44.76 M | 71.36 M | 65.85 M | 81.50 M | 99.22 M | 129.50 M | 105.40 M | 129.86 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 42.38 M | 68.89 M | 62.18 M | 83.23 M | 89.07 M | 121.04 M | 112.50 M | 122.35 M | 155.64 M | 176.72 M | 146.60 M | 178.50 M | 198.35 M | 202.42 M | 179.84 M | 214.66 M | ||||||||||
| Low Estimate | 37.56 M | 60.30 M | 54.06 M | 74.16 M | 81.28 M | 99.30 M | 100.86 M | 108.63 M | 146.19 M | 157.07 M | 120.49 M | 150.58 M | 186.16 M | 176.74 M | 165.89 M | 195.29 M | ||||||||||
| Consensus Estimate | 39.97 M | 64.59 M | 58.12 M | 78.70 M | 85.18 M | 110.17 M | 106.68 M | 115.49 M | 150.91 M | 166.90 M | 133.54 M | 164.54 M | 192.26 M | 189.58 M | 172.87 M | 204.97 M |
Analysts expect Arcutis Biotherapeutics, Inc. to report earnings per share of 0.17 for Q3 26, against a range of 0.16 to 0.18. The most recent reported quarter, Q2 26, came in at 0.11, a 83.3% beat against the 0.06 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.33 | -0.09 | -0.20 | -0.13 | 0.06 | 0.13 | -0.09 | 0.11 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.36 | -0.26 | -0.19 | -0.15 | -0.07 | 0.10 | -0.05 | 0.06 | 0.18 | 0.27 | 0.12 | 0.25 | 0.42 | 0.47 | 0.37 | 0.52 | ||||||||||
| Low Estimate | -0.42 | -0.30 | -0.21 | -0.17 | -0.09 | 0.08 | -0.07 | 0.06 | 0.16 | 0.25 | 0.10 | 0.21 | 0.36 | 0.41 | 0.31 | 0.44 | ||||||||||
| Consensus Estimate | -0.39 | -0.28 | -0.20 | -0.16 | -0.08 | 0.09 | -0.06 | 0.06 | 0.17 | 0.26 | 0.11 | 0.23 | 0.39 | 0.44 | 0.34 | 0.48 |
Pull Wall Street consensus for Arcutis Biotherapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ARQT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ARQT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ARQT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();